Histology and grade
Endometrioid, serous, clear cell, carcinosarcoma or other type and tumor grade are clarified.
Oncology evaluation directory
Gynecologic oncology
Uterine Cancer Evaluation
A gynecologic-oncology review for uterine and endometrial cancers, focused on histology, grade, stage, MMR/MSI or p53 context, prior surgery, radiation, chemotherapy and current pelvic or metastatic disease status.
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic
What the specialist needs to understand before any treatment discussion.
Uterine cancer is not one uniform diagnosis. Endometrioid, serous, clear cell, carcinosarcoma and sarcoma-type tumors require different review questions. Stage, grade and molecular markers can affect interpretation.
The file should show whether the patient is newly diagnosed, post-surgery, recurrent or metastatic, and whether the main issue is pelvic disease, distant spread or treatment tolerance.
Molecular context
MMR/MSI, p53, POLE or other markers are included when available.
Surgery status
Hysterectomy, lymph node assessment, margins and operative findings are documented.
Stage and recurrence
Pelvic, nodal, peritoneal, lung or other metastatic sites are summarized.
Prior therapy
Radiation, chemotherapy, immunotherapy, hormonal therapy and response are listed.
Current symptoms
Bleeding, pelvic pain, discharge, anemia, urinary/bowel symptoms and performance status are included.
Evaluation matrix
How the case is reviewed without reducing it to a diagnosis name.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Histology matters
Aggressive histologies require different interpretation than low-grade endometrioid tumors.
Molecular profile helps
MMR/MSI or p53 context can influence specialist discussion.
Pelvic recurrence risk
Prior surgery and radiation history affect local control questions.
Systemic tolerance
Blood counts, neuropathy, kidney/liver function and fatigue are reviewed.
Documents to prepare
A complete medical file prevents delay and unrealistic expectations.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
Cuba context
How Cuba-related options are framed responsibly.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Gynecologic-oncology framing
The file is routed according to histology, stage and prior treatment.
Symptoms influence timing
Active bleeding or infection may require local care before international review.
No universal claim
International coordination does not replace specialist suitability decisions.
Cuba context and clinical priority
Uterine cancer: what has to be clear first
No Cuba-related option takes precedence over proven standard treatment.
In uterine (endometrial) cancer, treatment follows histological type, grade, depth of myometrial invasion and molecular classification. POLE mutation, mismatch repair deficiency and p53 status now directly affect risk grouping and treatment intensity. Surgery is the foundation of treatment in most cases.
Cuba-related products have been studied in specific tumour types and are licensed in Cuba within their own approved indications. In this diagnosis the real contribution of an international review is to re-examine the current plan, check whether an option has been missed, and identify what is missing from the file. That is only possible with a complete and current record.
The file should therefore contain the full pathology report, staging imaging, a list of treatments given with dates and doses, current blood tests and the most recent oncology consultation note. An incomplete file causes both misdirection and avoidable delay.
Pathology and stage
Histological type, grade, depth of invasion and nodal status should appear in the report.
Molecular markers
MMR/MSI, p53 and POLE status determine risk group and treatment intensity.
Treatment history
Surgery performed, radiotherapy including brachytherapy, and systemic therapy should be listed.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
- Heavy bleeding, severe anemia symptoms or fainting.
- Fever, severe pelvic pain or suspected infection.
- Rapid abdominal swelling, bowel obstruction symptoms or sudden weakness.
Coordination pathway
From records to written next steps.
- File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items.
- Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
- Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page mean I am suitable for a Cuba-based treatment?
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
Can I send only a short summary?
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
Will the coordinator choose my treatment?
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
What happens if my file is incomplete?
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
Can urgent symptoms be handled through this page?
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
Related evaluation pages
Other oncology files reviewed in the same clinical directory.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.